Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedMay 25, 2026
DataAggregated Company Financials
Companies9
  • 7D5.9%
  • 3M8.3%
  • 1Y-13.7%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 4.1%, driven by gains from AddLife of 4.3%. However, the industry is down 11% over the past year. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 25 May 2026SEK 30.0bSEK 14.6b-SEK 849,175,077.0037.7x-35.4x2.1x
Wed, 22 Apr 2026SEK 31.3bSEK 14.6b-SEK 971,664,077.0036.6x-32.3x2.1x
Fri, 20 Mar 2026SEK 26.5bSEK 14.6b-SEK 838,374,077.0031.7x-31.6x1.8x
Sun, 15 Feb 2026SEK 27.0bSEK 14.9b-SEK 553,301,427.0032.8x-48.8x1.8x
Tue, 13 Jan 2026SEK 30.7bSEK 14.9b-SEK 744,515,427.0048.1x-41.2x2.1x
Thu, 11 Dec 2025SEK 33.0bSEK 14.9b-SEK 744,515,427.0054.9x-44.3x2.2x
Sat, 08 Nov 2025SEK 34.5bSEK 14.7b-SEK 742,825,012.0051.6x-46.4x2.3x
Mon, 06 Oct 2025SEK 34.5bSEK 14.7bSEK 61.3m58.7x562.8x2.4x
Wed, 03 Sep 2025SEK 34.5bSEK 14.7bSEK 60.9m55.4x566.4x2.4x
Fri, 01 Aug 2025SEK 36.2bSEK 14.8bSEK 186.0m59.2x194.9x2.5x
Sun, 29 Jun 2025SEK 46.7bSEK 16.6bSEK 405.8m68.5x115.1x2.8x
Tue, 27 May 2025SEK 45.9bSEK 16.6bSEK 401.3m69.5x114.4x2.8x
Thu, 24 Apr 2025SEK 41.8bSEK 16.6bSEK 580.4m45.7x72x2.5x
Sat, 22 Mar 2025SEK 37.2bSEK 16.6bSEK 614.3m38x60.5x2.2x
Mon, 17 Feb 2025SEK 43.7bSEK 17.0b-SEK 1,033,505,426.0042.5x-42.3x2.6x
Wed, 15 Jan 2025SEK 40.7bSEK 16.7b-SEK 1,152,911,426.0041.9x-35.3x2.4x
Fri, 13 Dec 2024SEK 44.2bSEK 16.7b-SEK 1,152,911,426.0050.8x-38.3x2.6x
Sun, 10 Nov 2024SEK 44.3bSEK 16.8b-SEK 948,072,426.0050.7x-46.8x2.6x
Tue, 08 Oct 2024SEK 46.8bSEK 16.7b-SEK 988,175,491.0057.9x-47.3x2.8x
Thu, 05 Sep 2024SEK 48.0bSEK 16.7b-SEK 987,374,492.0060.7x-48.6x2.9x
Sat, 03 Aug 2024SEK 47.4bSEK 16.7b-SEK 1,128,120,510.0059.9x-42x2.8x
Mon, 01 Jul 2024SEK 42.0bSEK 16.3b-SEK 1,188,686,510.0055.3x-35.3x2.6x
Wed, 29 May 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0060.3x-35.5x2.6x
Fri, 26 Apr 2024SEK 37.0bSEK 16.3b-SEK 1,244,732,213.0035.5x-29.7x2.3x
Sun, 24 Mar 2024SEK 38.8bSEK 16.0b-SEK 1,122,792,210.0036x-34.6x2.4x
Tue, 20 Feb 2024SEK 40.8bSEK 16.1b-SEK 1,406,407,350.0047.3x-29x2.5x
Thu, 18 Jan 2024SEK 36.4bSEK 15.5b-SEK 1,393,723,683.0044x-26.1x2.4x
Sat, 16 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0047.6x-27.4x2.5x
Mon, 13 Nov 2023SEK 31.2bSEK 15.4b-SEK 1,256,647,710.0034x-24.8x2x
Wed, 11 Oct 2023SEK 26.5bSEK 15.1b-SEK 1,134,516,711.0035.7x-23.4x1.8x
Fri, 08 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.1x-25.8x1.9x
Sun, 06 Aug 2023SEK 32.1bSEK 15.1b-SEK 213,871,038.0046.7x-150.2x2.1x
Tue, 04 Jul 2023SEK 36.3bSEK 14.6b-SEK 172,476,038.0035.9x-210.7x2.5x
Thu, 01 Jun 2023SEK 38.8bSEK 14.6b-SEK 173,602,038.0038.8x-223.4x2.6x
Price to Earnings Ratio

-223.4x


Total Market Cap: SEK 38.8bTotal Earnings: -SEK 173,602,038.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 16.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market2.74%
Healthcare4.05%
Life Sciences5.92%
Clinical Research and Equipment5.92%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 150.906.1%
+SEK 1.1b		-18.2%PE32.4x
MCAP MedCapSEK 565.506.6%
+SEK 525.7m		26.9%PE37.7x
BICO BICO GroupSEK 18.826.0%
+SEK 74.8m		-48.4%PS0.9x
GENO Genovis AB (publ.)SEK 20.452.3%
+SEK 29.7m		-22.5%PE55.6x
LEVBIO Level BioSEK 0.3423.5%
+SEK 4.4m		-25.3%PS0.7x

Latest News

PRO
SEK 11.20
Promimic
7D
-5.9%
1Y
-34.5%
MAGLE
SEK 4.22
Magle Chemoswed Holding
7D
-0.5%
1Y
-84.0%
LEVBIO
SEK 0.34
Level Bio
7D
23.5%
1Y
-25.3%
IDLDX
SEK 0.47
IDL Diagnostics
7D
-1.1%
1Y
-18.1%
MCAP
SEK 565.50
MedCap
7D
6.6%
1Y
26.9%
ALIF B
SEK 150.90
AddLife
7D
6.1%
1Y
-18.2%
BICO
SEK 18.82
BICO Group
7D
6.0%
1Y
-48.4%
GENO
SEK 20.45
Genovis AB (publ.)
7D
2.3%
1Y
-22.5%
Analysis Article • May 01

Genovis AB (publ.) Just Missed Earnings - But Analysts Have Updated Their Models

Genovis AB (publ.) ( STO:GENO ) shareholders are probably feeling a little disappointed, since its shares fell 4.4% to...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%